Sarcoidosis is an idiopathic granulomatous disease that is well known to affect the central nervous system (CNS). The frequency of CNS involvement in sarcoidosis is reported to be approximately 5%.' Most of the manifestations of CNS sarcoidosis are a result of a granulomatous basilar meningitis with infiltration or compression of adjacent structures. This usually results in cranial nerve dysfunction, the seventh cranial nerve being most commonly involved. Optic nerve, optic chiasm, brain stem, pituitary, hypothalmus and cerebellum may also be affected.' In addition, CNS sarcoidosis can also present as a mass lesion masquerading as a neoplasm with focal cortical, as well as diffuse cortical dysfunction (seizures).2 Sarcoidosis presenting solely in the anterior visual pathway without other ophthalmic or CNS signs is rare.34 In spite of this, we present four patients with intracranial optic nerve and chiasmal sarcoidosis all of whom complained of a visual loss as their first symptoms. Although corticosteroid therapy is considered to be the mainstay in the treatment ofCNS sarcoidosis,5 our patients were unable to tolerate the doses of systemic corticosteroids necessary to prevent progressive visual loss. Alternative intervention was required to prevent visual loss. The role of radiation therapy and immun-osuppressive (cytotoxic) therapy, their putative mechanisms and their effectiveness, are discussed.
Case reports
Case I (table 1) A 45 year old black woman experienced painful decrease of vision in the right eye for one month in August 1984. Initially, the vision deteriorated over one week but responded to oral prednisone (80 mg) therapy given to her prior to our evaluation, which was when the visual loss recurred as the prednisone was reduced. She had no other neurological or general medical symptoms. Her past medical history included hypertension controlled by a low sodium diet.
Examination (by MJK) revealed a Snellen acuity of 20/40 in the right eye and 20/20 in the left. The colour vision was severely impaired in the right eye by Ishihara testing. Her pupils were 3 mm in size, round and reactive to light with a moderate relative afferent pupillary defect on the right side. The anterior segment and intraocular pressures were normal. Visual fields on a tangent screen at I m demonstrated a generalised constriction in the right eye to the 2 mm (100) and 5 mm (150) white test objects; the visual field of the left eye was normal. Ophthalmoscopic evaluation revealed diffuse yellow pallor of the right optic disc with a diffuse, mild thinning of the nerve fiber layer and a normal left eye fundus. The prednisone was reinstituted at 80 mg a day. The remainder of her neurological evaluation and blood pressure were normal.
Blood laboratory tests, including haemogram, erythrocyte sedimentation rate, antinuclear antibody, VDRL, FTA-ABS, latex fixation and angiotensin converting enzyme, were negative. A chest radiograph showed fullness bilaterally in the hilar region. A contrast CT scan of the head and orbits demonstrated pansinusitis and an enhancing mass in the area of the planum sphenoidale and olfactory groove that extended into the right orbit. (fig 1) .
At craniotomy a mass was seen involving the tuberculum sellae and suprasellar area as well as the right carotid artery. The surgeon thought the lesion was inflammatory in nature, and it could not be separated from the carotid artery. A partial resection was performed to decompress the right optic nerve and chiasm. Histopathology showed chronic noncaseating granulomatous disease consistent with the diagnosis of sarcoidosis. Perioperative intravenous solumedrol 120 mg four times daily was reduced and she was discharged on 80 mg/day of prednisone orally. Her 20/25 acuity and visual field remained stable for 2 years on prednisone but any attempt to decrease the dose below 40 mg daily resulted in visual deterioration. Hydrochlorothiazide was required to control a rise in the blood pressure. The fasting blood sugar fluctuated between 200 mg/100 ml and 300 mg/100 ml.
The patient developed a left hemiparesis and left facial weakness one year after surgery in August 1985. A right cerebral infarction seen on CT was presumed to be associated with the systemic hypertension or was secondary to the granulomatous process involving the carotid artery. The Examination (by RMB) revealed a healthy looking black man. Corrected Snellen acuity was 20/20 in the right eye and 20/200 in the left. Brightness discrimination and colour saturation were decreased by 50% in the left eye compared with the right. The right eye colour vision was mildly abnormal, but with the exception of the control plate he could not identify any of the pseudoisochromatic plates with his left eye. Both pupils were round, equal and reacted to light. A relative afferent pupillary defect was present in the left eye. The anterior segment was normal. Applanation pressures were 9 mm Hg in the right eye and 11 mm Hg in the left.
The optic discs in both eyes had pale temporal rims, a cup/ disc ratio of 0-7 in the horizontal and vertical meridians and diffuse nerve fibre layer dropout. The maculas and peripheral retinas were normal bilaterally. Kinetic visual fields performed on the Goldmann perimeter showed a left junctional scotoma, central scotoma to l2e and I4e with the left eye and superior temporal depression to a 12e with the right eye. The neurological examination was otherwise normal.
Contrast enhanced CT demonstrated an enhancing midline mass in the suprasellar cistern ( fig 3) The optic disc in the left eye was chalk-white with attenuated blood vessels. The right disc was diffusely pale. In neither eye was there evidence of chorioretinitis or changes (fig 4) .
The patient was treated with 1,000 mg of intravenous methylprednisolone every 12 hours for five days. He was discharged on oral prednisone, 100 mg daily for one month. Despite this therapy, visual acuity in the right eye deteriorated further to 20/400 with loss ofthe superior part of the remaining nasal field.
Another exploratory craniotomy was performed in July, 1982, at the University of Nebraska. Biopsy of tissue in the suprasellar area confirmed the diagnosis of sarcoidosis. Because of continued subjective deterioration, a course of radiation therapy was delivered to the suprasellar area with a total dose of 2,600 cGy in 200 cGy fractions.
For eight months, the visual acuity in his right eye remained stable at 20/300. The kinetic visual field was also unchanged during this time. Unfortunately, this patient was "lost to follow up", despite many attempts to communicate with him. methotrexate,'0 azathioprine," and chloroquine,'2 used alone or in addition to corticosteroids in the treatment of sarcoidosis located outside the CNS, show variable results. The mechanism of action of these drugs must relate to an effect on the immunopathology of sarcoidosis, which is yet to be fully understood. There are three possible sites where immunotherapy may alter the granulomatous process. A type IV delayed hypersensitivity reaction characterised by fibrinogen deposition9 has been established. A type II cytotoxic (cell stimulating) reaction in response to an unknown antigen is indicated by immunofluorescent demonstration of immunoglobulin and complement (specifically C3 and C4) in the sarcoid granuloma.'3 An angiitic form of neurosarcoidosis also has been reported.'415 True arthus-type antigen antibody immune complex deposition in the blood vessels may be the cause, but there is no pathological confinnation of this hypothesis. '3 Corticosteroids may prevent granuloma formation by suppressing the synthesis of lymphokines and by blocking the action of lymphokines on monocytes, so their migration is inhibited.'6 Cytotoxic (immunosuppressive) agents reduce the number of available mononuclear cells by suppressing bone marrow activity. The reduction of mononuclear cells responsible for the cytotoxic, type II, immune response may explain the effectiveness of these agents in our cases. It is also known that these cytotoxic agents may potentiate the anti-inflammatory effect of steroids by altering several steps in the pathway of chronic inflammation. 9 Sarcoidosis of the intracranial anterior visual pathway occurs infrequently and is often difficult to diagnose, but once the diagnosis is established, intensive therapy should be considered. Despite systemic corticosteroid and radiation therapy, blindness can occur, and long term use of corticosteroids is poorly tolerated by patients. Early institution of immuno- 
